De Novo Mutation in an Enhancer of EBF3 in simplex autism
Authors:
- Evin M. PadhiEPEvin M. Padhi
- Tristan J. HayeckTHTristan J. Hayeck
- Brandon MannionBMBrandon Mannion
- Sumantra ChatterjeeSCSumantra Chatterjee
- Marta Byrska-BishopMBMarta Byrska-Bishop
- Rajeeva MusunuriRMRajeeva Musunuri
- Giuseppe NarzisiGNGiuseppe Narzisi
- Avinash AbhyankarAAAvinash Abhyankar
- Riana D. HunterRHRiana D. Hunter
- Jennifer AkiyamaJAJennifer Akiyama
- Lauren E. FriesLFLauren E. Fries
Preprint
Abstract
Previous research in autism and other neurodevelopmental disorders (NDDs) has indicated an important contribution of de novo protein-coding variants within specific genes. The role of de novo noncoding variation has been observable as a general increase in genetic burden but has yet to be resolved to individual functional elements. In this study, we assessed whole-genome sequencing data in 2,671 families with autism, with a specific focus on de novo variation in enhancers with previously characterized in vivo activity. We identified three independent de novo mutations limited to individuals with autism in the enhancer hs737. These mutations result in similar phenotypic characteristics, affect enhancer activity in vitro , and preferentially occur in AAT motifs in the enhancer with predicted disruptions of transcription factor binding. We also find that hs737 is enriched for copy number variation in individuals with NDDs, is dosage sensitive in the human population, is brain-specific, and targets the NDD gene EBF3 that is genome-wide significant for protein coding de novo variants, demonstrating the importance of understanding all forms of variation in the genome. One Sentence Summary: Whole-genome sequencing in thousands of families reveals variants relevant to simplex autism in a brain enhancer of the well-established neurodevelopmental disorder gene EBF3 .Keywords
All Related Versions
- Published version: Human Genomics, 15 (1), 1.
This publication has 65 references indexed in Scilit:
- Topological domains in mammalian genomes identified by analysis of chromatin interactionsNature, 2012
- Patterns and rates of exonic de novo mutations in autism spectrum disordersNature, 2012
- Sporadic autism exomes reveal a highly interconnected protein network of de novo mutationsNature, 2012
- De novo mutations revealed by whole-exome sequencing are strongly associated with autismNature, 2012
- De Novo Gene Disruptions in Children on the Autistic SpectrumNeuron, 2012
- ChromHMM: automating chromatin-state discovery and characterizationNature Methods, 2012
- A copy number variation morbidity map of developmental delayNature Genetics, 2011
- Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutationsNature Genetics, 2011
- Finding the missing heritability of complex diseasesNature, 2009
- In vivo enhancer analysis of human conserved non-coding sequencesNature, 2006